DCGO
DCGO
DocGo Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $74.94M ▲ | $56.81M ▼ | $-134.07M ▼ | -178.91% ▼ | $-1.37 ▼ | $-28.49M ▼ |
| Q3-2025 | $70.81M ▼ | $60.1M ▲ | $-27.77M ▼ | -39.22% ▼ | $-0.28 ▼ | $-21.27M ▼ |
| Q2-2025 | $80.42M ▼ | $42.9M ▼ | $-11.16M ▼ | -13.87% ▼ | $-0.11 ▼ | $-13.49M ▼ |
| Q1-2025 | $96.03M ▼ | $44.85M ▼ | $-9.41M ▼ | -9.79% ▼ | $-0.09 ▼ | $-10.62M ▼ |
| Q4-2024 | $120.83M | $47.97M | $-3.26M | -2.7% | $-0.03 | $-3.16M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $51.02M ▼ | $217.1M ▼ | $91.23M ▼ | $144.01M ▼ |
| Q3-2025 | $73.36M ▼ | $353.78M ▼ | $93.12M ▼ | $270.53M ▼ |
| Q2-2025 | $104.16M ▲ | $408.26M ▼ | $120.53M ▼ | $297.28M ▼ |
| Q1-2025 | $79.01M ▼ | $430.79M ▼ | $128.87M ▼ | $309.34M ▼ |
| Q4-2024 | $89.24M | $455.62M | $140.44M | $320.92M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-142.34M ▼ | $-10.47M ▼ | $-13.07M ▼ | $-1.86M ▲ | $-25.12M ▲ | $-12.6M ▼ |
| Q3-2025 | $-29.66M ▼ | $1.66M ▼ | $1.1M ▲ | $-33.05M ▼ | $-30.95M ▼ | $101.16K ▼ |
| Q2-2025 | $-13.29M ▼ | $33.6M ▲ | $-21.38M ▼ | $-7.38M ▲ | $5.5M ▲ | $32.04M ▲ |
| Q1-2025 | $-11.08M ▼ | $9.66M ▼ | $-5.73M ▼ | $-8.52M ▼ | $-4.28M ▼ | $7.47M ▼ |
| Q4-2024 | $-7.65M | $12.89M | $-5.57M | $-7.86M | $-1.24M | $12.22M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Mobile Health Services Segment | $70.00M ▲ | $50.00M ▼ | $30.00M ▼ | $50.00M ▲ |
Transportation Services Segment | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $100.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
UNITED KINGDOM | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $30.00M ▲ |
UNITED STATES | $110.00M ▲ | $80.00M ▼ | $70.00M ▼ | $120.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at DocGo Inc.'s financial evolution and strategic trajectory over the past five years.
DocGo combines a meaningful revenue base, strong liquidity, and a distinctive strategic position in mobile and virtual healthcare. Its balance sheet shows ample cash and modest leverage, giving it time to refine its model. The company’s proprietary technology platform, hybrid care capabilities, and focus on “last-mile” healthcare delivery create clear differentiation in a market that increasingly values home-based and preventive care. Positive operating and free cash flow, despite large accounting losses, indicate some underlying operational resilience and support continued investment in innovation.
The largest risks are financial and execution-related. Profitability is deeply negative, and accumulated losses are significant, reflecting a cost structure that currently outstrips the economics of its contracts. If operating expenses—especially overhead and technology investments—are not brought into better balance with gross profit, the current cash cushion could erode over time. Competitive and regulatory pressures add further uncertainty: powerful incumbents, contract concentration, reimbursement changes, and operational complexity all pose challenges. The ambitious innovation agenda also carries execution risk; integrating acquisitions, deploying AI, and scaling complex services without compromising quality is difficult.
The outlook for DocGo is mixed but strategically interesting. On one side, the company is aligned with powerful trends toward in-home care, telehealth, and cost containment, and it has built technology and service capabilities that many healthcare stakeholders are actively seeking. Management’s stated intent to pivot toward higher-margin business and achieve adjusted EBITDA profitability suggests a focus on improving economics. On the other side, current financials show that this transition is still in progress, with substantial losses and a need for disciplined cost management. The path forward will likely hinge on DocGo’s ability to convert its innovative model and strong customer value proposition into consistent, scalable profitability while preserving its balance sheet strength.
About DocGo Inc.
https://www.docgo.comDocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $74.94M ▲ | $56.81M ▼ | $-134.07M ▼ | -178.91% ▼ | $-1.37 ▼ | $-28.49M ▼ |
| Q3-2025 | $70.81M ▼ | $60.1M ▲ | $-27.77M ▼ | -39.22% ▼ | $-0.28 ▼ | $-21.27M ▼ |
| Q2-2025 | $80.42M ▼ | $42.9M ▼ | $-11.16M ▼ | -13.87% ▼ | $-0.11 ▼ | $-13.49M ▼ |
| Q1-2025 | $96.03M ▼ | $44.85M ▼ | $-9.41M ▼ | -9.79% ▼ | $-0.09 ▼ | $-10.62M ▼ |
| Q4-2024 | $120.83M | $47.97M | $-3.26M | -2.7% | $-0.03 | $-3.16M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $51.02M ▼ | $217.1M ▼ | $91.23M ▼ | $144.01M ▼ |
| Q3-2025 | $73.36M ▼ | $353.78M ▼ | $93.12M ▼ | $270.53M ▼ |
| Q2-2025 | $104.16M ▲ | $408.26M ▼ | $120.53M ▼ | $297.28M ▼ |
| Q1-2025 | $79.01M ▼ | $430.79M ▼ | $128.87M ▼ | $309.34M ▼ |
| Q4-2024 | $89.24M | $455.62M | $140.44M | $320.92M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-142.34M ▼ | $-10.47M ▼ | $-13.07M ▼ | $-1.86M ▲ | $-25.12M ▲ | $-12.6M ▼ |
| Q3-2025 | $-29.66M ▼ | $1.66M ▼ | $1.1M ▲ | $-33.05M ▼ | $-30.95M ▼ | $101.16K ▼ |
| Q2-2025 | $-13.29M ▼ | $33.6M ▲ | $-21.38M ▼ | $-7.38M ▲ | $5.5M ▲ | $32.04M ▲ |
| Q1-2025 | $-11.08M ▼ | $9.66M ▼ | $-5.73M ▼ | $-8.52M ▼ | $-4.28M ▼ | $7.47M ▼ |
| Q4-2024 | $-7.65M | $12.89M | $-5.57M | $-7.86M | $-1.24M | $12.22M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
Mobile Health Services Segment | $70.00M ▲ | $50.00M ▼ | $30.00M ▼ | $50.00M ▲ |
Transportation Services Segment | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $100.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|
UNITED KINGDOM | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $30.00M ▲ |
UNITED STATES | $110.00M ▲ | $80.00M ▼ | $70.00M ▼ | $120.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at DocGo Inc.'s financial evolution and strategic trajectory over the past five years.
DocGo combines a meaningful revenue base, strong liquidity, and a distinctive strategic position in mobile and virtual healthcare. Its balance sheet shows ample cash and modest leverage, giving it time to refine its model. The company’s proprietary technology platform, hybrid care capabilities, and focus on “last-mile” healthcare delivery create clear differentiation in a market that increasingly values home-based and preventive care. Positive operating and free cash flow, despite large accounting losses, indicate some underlying operational resilience and support continued investment in innovation.
The largest risks are financial and execution-related. Profitability is deeply negative, and accumulated losses are significant, reflecting a cost structure that currently outstrips the economics of its contracts. If operating expenses—especially overhead and technology investments—are not brought into better balance with gross profit, the current cash cushion could erode over time. Competitive and regulatory pressures add further uncertainty: powerful incumbents, contract concentration, reimbursement changes, and operational complexity all pose challenges. The ambitious innovation agenda also carries execution risk; integrating acquisitions, deploying AI, and scaling complex services without compromising quality is difficult.
The outlook for DocGo is mixed but strategically interesting. On one side, the company is aligned with powerful trends toward in-home care, telehealth, and cost containment, and it has built technology and service capabilities that many healthcare stakeholders are actively seeking. Management’s stated intent to pivot toward higher-margin business and achieve adjusted EBITDA profitability suggests a focus on improving economics. On the other side, current financials show that this transition is still in progress, with substantial losses and a need for disciplined cost management. The path forward will likely hinge on DocGo’s ability to convert its innovative model and strong customer value proposition into consistent, scalable profitability while preserving its balance sheet strength.

CEO
Lee Bienstock
Compensation Summary
(Year 2023)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 50
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:7.04M
Value:$4.56M
BLACKROCK, INC.
Shares:6.43M
Value:$4.17M
VANGUARD GROUP INC
Shares:5.09M
Value:$3.3M
Summary
Showing Top 3 of 142

